Metabolic and genetic influence on glucose metabolism in type 2 diabetic subjects—experiences from relatives and twin studies

Henning Beck-Nielsen1
1Odense University Hospital, Kloevervaenget 6, 4, 5000 Odense C, Denmark

Tài liệu tham khảo

Beck-Nielsen, 1994, Metabolic and genetic characterization of prediabetic states. Sequence of events leading to non-insulin-dependent diabetes mellitus, Journal of Clinical Investigation, 94, 1714, 10.1172/JCI117518 Beck-Nielsen, 2000, Obesity in type 2 diabetes mellitus, 567 Hales, 1991, Fetal and infant growth and impaired glucose tolerance at age 64, British Medical Journal, 303, 1019, 10.1136/bmj.303.6809.1019 Harvald, 1965, Hereditary factors elucidated by twin studies, 61 Poulsen, 1999, Heritability of type II (non-insulin-dependent) diabetes mellitus and abnormal glucose tolerance—a population-based twin study, Diabetologia, 42, 139, 10.1007/s001250051131 Neale, 1992 Tattersall, 1972, Diabetes in identical twins, Lancet, ii, 1120, 10.1016/S0140-6736(72)92720-1 1988, Diabetes mellitus in twins: a cooperative study in Japan, Diabetes Research Clinical Practice, 5, 271, 10.1016/S0168-8227(88)80062-7 Newman, 1987, Concordance for type 2 (non-insulin-dependent) diabetes mellitus in male twins, Diabetologia, 30, 763, 10.1007/BF00275741 Barnett, 1981, Diabetes in identical twins. A study of 200 pairs, Diabetologia, 20, 87, 10.1007/BF00262007 Kaprio, 1992, Concordance for type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitus in a population-based cohort of twins in Finland, Diabetologia, 35, 1060, 10.1007/BF02221682 Newman, 1987, Concordance for type 2 (non-insulin-dependent) diabetes mellitus in male twins, Diabetologia, 30, 763, 10.1007/BF00275741 Kobberling, 1982 Poulsen, 2001, Genetic versus environmental aetiology of the metabolic syndrome among male and female twins, Diabetologia, 44, 537, 10.1007/s001250051659 Hong, 1997, Genetic and environmental architecture of the features of the insulin-resistance syndrome, American Journal of Human Genetics, 60, 143 Mayer, 1996, Genetic and environmental influences on insulin levels and the insulin resistance syndrome: an analysis of women twins, American Journal of Epidemiology, 143, 323, 10.1093/oxfordjournals.aje.a008746 Bouchard, 1990, The response to long-term overfeeding in identical twins, New England Journal of Medicine, 322, 1477, 10.1056/NEJM199005243222101 Selby, 1990, Genetic and behavioral influences on body fat distribution, International Journal of Obesity and Related Metabolic Disorders, 14, 593 Cardon, 1994, Genetic and environmental correlations between obesity and body fat distribution in adult male twins, Human Biology, 66, 465 Poulsen, 1997, Low birth weight is associated with NIDDM in discordant monozygotic and dizygotic twin pairs, Diabetologia, 40, 439, 10.1007/s001250050698 Phipps, 1993, Fetal growth and impaired glucose tolerance in men and women, Diabetologia, 36, 225, 10.1007/BF00399954 Phillips, 1994, Fetal growth and insulin secretion in adult life, Diabetologia, 37, 592, 10.1007/BF00403378 Phillips, 1993, Twin studies in medical research: can they tell us whether diseases are genetically determined?, Lancet, 341, 1008, 10.1016/0140-6736(93)91086-2 Ramos-Arroyo, 1988, Twin study: relationship between birth weight, zygosity, placentation, and pathologic placental changes, Acta Geneticae Medicae Gemellol (Roma), 37, 229, 10.1017/S0001566000003834 Naeye, 1964, The fetal and neonatal development of twins, Pediatrics, 33, 546, 10.1542/peds.33.4.546 McDonald, 1993, Twin studies in medical research, Lancet, 341, 1419 Poulsen, 1999, Does zygosity influence the metabolic profile of twins? A population based cross sectional study, British Medical Journal, 319, 151, 10.1136/bmj.319.7203.151 Poulsen, 2002, Age-dependent impact of zygosity and birth weight on insulin secretion and insulin action in twins, Diabetologia, 45, 1649, 10.1007/s00125-002-0983-6 Christiansen, 1999, The Trp64Arg mutation of the adrenergic beta-3 receptor gene impairs insulin secretion: a twin study, Diabetic Medicine, 16, 835, 10.1046/j.1464-5491.1999.00130.x Fenger, 2000, Impact of the Xba1-polymorphism of the human muscle glycogen synthase gene on parameters of the insulin resistance syndrome in a Danish twin population, Diabetic Medicine, 17, 735, 10.1046/j.1464-5491.2000.00377.x Bentzen, 2002, The influence of the polymorphism in apolipoprotein B codon 2488 on insulin and lipid levels in a Danish twin population, Diabetic Medicine, 19, 12, 10.1046/j.0742-3071.2001.00602.x Poulsen, 2003, Impact of two common polymorphisms in the PPARgamma gene on glucose tolerance and plasma insulin profiles in monozygotic and dizygotic twins: thrifty genotype, thrifty phenotype, or both?, Diabetes, 52, 194, 10.2337/diabetes.52.1.194 Yki-Jäsrvinen, 1992, Glucose toxicity, Endocrine Reviews, 13, 415 Nyholm, 2000, What have metabolic studies in healthy relatives taught us about the pathogenesis of type 2 diabetes? Kahn, 1986, Insulin resistance: a common feature of diabetes mellitus (editorial), New England Journal of Medicine, 315, 252, 10.1056/NEJM198607243150410 Vaag, 1992, Decreased insulin activation of glycogen synthase in skeletal muscles in young nonobese Caucasian first-degree relatives of patients with non-insulin-dependent diabetes mellitus, Journal of Clinical Investigation, 89, 782, 10.1172/JCI115656 Vaag, 1995, Insulin secretion, insulin action, and hepatic glucose production in identical twins discordant for non-insulin-dependent diabetes mellitus, Journal of Clinical Investigation, 95, 690, 10.1172/JCI117715 Vaag, 1996, Intracellular glucose and fat metabolism in identical twins discordant for non-insulin-dependent diabetes mellitus (NIDDM): acquired versus genetic metabolic defects?, Diabetic Medicine, 13, 806, 10.1002/(SICI)1096-9136(199609)13:9<806::AID-DIA179>3.0.CO;2-5 Pimenta, 1995, Pancreatic beta-cell dysfunction as the primary genetic lesion in NIDDM. Evidence from studies in normal glucose-tolerant individuals with a first-degree NIDDM relative, Journal of the American Medical Association, 273, 1855, 10.1001/jama.273.23.1855 Alcolado, 1991, Importance of maternal history of non-insulin dependent diabetic patients, British Medical Journal, 302, 1178, 10.1136/bmj.302.6786.1178 Humphriss, 1997, Multiple metabolic abnormalities in normal glucose tolerant relatives of NIDDM families, Diabetologia, 40, 1185, 10.1007/s001250050805 Migdalis, 1996, Metabolic abnormalities in offspring of NIDDM patients with a family history of diabetes mellitus, Diabetic Medicine, 13, 434, 10.1002/(SICI)1096-9136(199605)13:5<434::AID-DIA102>3.0.CO;2-R Perseghin, 1997, Metabolic defects in lean nondiabetic offspring of NIDDM parents: a cross-sectional study, Diabetes, 46, 1001, 10.2337/diabetes.46.6.1001 Vaag, 2001, Metabolic impact of a family history of type 2 diabetes. Results from a European multicentre study (EGIR), Diabetic Medicine, 18, 533, 10.1046/j.1464-5491.2001.00496.x Altshuler, 2000, The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes, Nature Genetics, 26, 76, 10.1038/79839 Ek, 2001, Studies of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma2 (PPAR-gamma2) gene in relation to insulin sensitivity among glucose tolerant caucasians, Diabetologia, 44, 1170, 10.1007/s001250100629 Ek, 2001, Mutation analysis of peroxisome proliferator-activated receptor-gamma coactivator-1 (PGC-1) and relationships of identified amino acid polymorphisms to type II diabetes mellitus, Diabetologia, 44, 2220, 10.1007/s001250100032 Bjorbaek, 1994, Genetic variants in promoters and coding regions of the muscle glycogen synthase and the insulin-responsive GLUT4 genes in NIDDM, Diabetes, 43, 976, 10.2337/diabetes.43.8.976 Almind, 1993, Aminoacid polymorphisms of insulin receptor substrate-1 in non-insulin-dependent diabetes mellitus, Lancet, 342, 828, 10.1016/0140-6736(93)92694-O Eriksson, 1989, Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus, New England Journal of Medicine, 321, 337, 10.1056/NEJM198908103210601 Schalin-Jantti, 1992, Impaired activation of glycogen synthase in people at increased risk for developing NIDDM, Diabetes, 41, 598, 10.2337/diabetes.41.5.598 Henry, 1996, Glycogen synthase activity is reduced in cultured skeletal muscle cells of non-insulin-dependent diabetes mellitus subjects. Biochemical and molecular mechanisms, Journal of Clinical Investigation, 98, 1231, 10.1172/JCI118906 Wells, 1993, Abnormal activation of glycogen synthesis in fibroblasts from NIDDM subjects. Evidence for an abnormality specific to glucose metabolism, Diabetes, 42, 583, 10.2337/diabetes.42.4.583 Gaster, 2002, The diabetic phenotype is conserved in myotubes established from diabetic subjects: evidence for primary defects in glucose transport and glycogen synthase activity, Diabetes, 51, 921, 10.2337/diabetes.51.4.921 Hojlund, 2003, Increased phosphorylation of skeletal muscle glycogen synthase at NH2-terminal sites during physiological hyperinsulinemia in type 2 diabetes, Diabetes, 10.2337/diabetes.52.6.1393 Rothman, 1995, Decreased muscle glucose transport/phosphorylation is an early defect in the pathogenesis of non-insulin-dependent diabetes mellitus, Proceedings of the National Academy of Sciences of the USA, 92, 983, 10.1073/pnas.92.4.983 Price, 1996, NMR studies of muscle glycogen synthesis in insulin-resistant offspring of parents with non-insulin-dependent diabetes mellitus immediately after glycogen-depleting exercise, Proceedings of the National Academy of Sciences of the USA, 93, 5329, 10.1073/pnas.93.11.5329 Perseghin, 1996, Increased glucose transport-phosphorylation and muscle glycogen synthesis after exercise training in insulin-resistant subjects, New England Journal of Medicine, 335, 1357, 10.1056/NEJM199610313351804 Meyer, 2002, Insulin signalling in human skeletal muscle of subjects with or without type II-diabetes and first degree relatives of patients with the disease, Diabetologia, 45, 813, 10.1007/s00125-002-0830-9 Storgaard, 2001, Insulin signal transduction in skeletal muscle from glucose-intolerant relatives of type 2 diabetic patients (corrected), Diabetes, 50, 2770, 10.2337/diabetes.50.12.2770 Colwell, 1967, Diminished insulin response to hyperglycemia in prediabetes and diabetes, Diabetes, 16, 560, 10.2337/diab.16.8.560 Soeldner, 1968, Diminished serum insulin response to glucose in genetic prediabetic males with normal glucose tolerance, Diabetes, 17, 17, 10.2337/diab.17.1.17 Fernandez-Castaner, 1996, Beta-cell dysfunction in first-degree relatives of patients with non-insulin-dependent diabetes mellitus, Diabetic Medicine, 13, 953, 10.1002/(SICI)1096-9136(199611)13:11<953::AID-DIA257>3.0.CO;2-V Schmitz, 1997, Disorderly and nonstationary insulin secretion in relatives of patients with NIDDM, American Journal of Physiology, 272, E218 Beck-Nielsen, 1994, Pathogenesis of type 2 (non-insulin-dependent) diabetes mellitus: the role of skeletal muscle glucose uptake and hepatic glucose production in the development of hyperglycaemia. A critical comment, Diabetologia, 37, 217, 10.1007/s001250050097 La Barre, 1932, Sur les possibilités d'un traitement du diabetes par l'incretine, Bulletin Academie royale de medecine Belge, 12, 620 Orskov, 1992, Glucagon-like peptide-1, a new hormone of the entero-insular axis, Diabetologia, 35, 701, 10.1007/BF00429088 Gaster, 2001, Proliferation conditions for human satellite cells. The fractional content of satellite cells, APMIS, 109, 726, 10.1034/j.1600-0463.2001.d01-139.x Gaster, 2001, A cellular model system of differentiated human myotubes, APMIS, 109, 735, 10.1034/j.1600-0463.2001.d01-140.x Henry, 1995, Insulin action and glucose metabolism in nondiabetic control and NIDDM subjects. Comparison using human skeletal muscle cell cultures, Diabetes, 44, 936, 10.2337/diabetes.44.8.936 Gaster, 2001, The basal kinetic parameters of glycogen synthase in human myotube cultures are not affected by chronic high insulin exposure, Biochimica et Biophysica Acta, 1537, 211, 10.1016/S0925-4439(01)00071-0 Krutzfeldt, 2000, Insulin signaling and action in cultured skeletal muscle cells from lean healthy humans with high and low insulin sensitivity, Diabetes, 49, 992, 10.2337/diabetes.49.6.992 Vollenweider, 2002, Insulin resistance, defective insulin receptor substrate 2-associated phosphatidylinositol-3prime; kinase activation, and impaired atypical protein kinase C (zeta/lambda) activation in myotubes from obese patients with impaired glucose tolerance, Diabetes, 51, 1052, 10.2337/diabetes.51.4.1052 Thompson, 1996, Human primary myoblast cell cultures from non-diabetic insulin resistant subjects retain defects in insulin action, Journal of Clinical Investigation, 98, 2346, 10.1172/JCI119046 Hales, 1992, Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis, Diabetologia, 35, 595, 10.1007/BF00400248 Jensen, 2002, Early differential defects of insulin secretion and action in 19-year-old caucasian men who had low birth weight, Diabetes, 51, 1271, 10.2337/diabetes.51.4.1271 Phillips, 1994, Thinness at birth and insulin resistance in adult life, Diabetologia, 37, 150, 10.1007/s001250050086 Boden, 1991, Effects of fat on insulin-stimulated carbohydrate metabolism in normal men, Journal of Clinical Investigation, 88, 960, 10.1172/JCI115399 Lewis, 2002, Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes, Endocrine Reviews, 23, 201, 10.1210/er.23.2.201 Kelley, 2000, Fuel selection in human skeletal muscle in insulin resistance: a reexamination, Diabetes, 49, 677, 10.2337/diabetes.49.5.677 Randle, 1963, The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus, Lancet, i, 785, 10.1016/S0140-6736(63)91500-9 Damsbo, 1991, Reduced glycogen synthase activity in skeletal muscle from obese patients with and without type 2 (non-insulin-dependent) diabetes mellitus, Diabetologia, 34, 239, 10.1007/BF00405082 Shulman, 2000, Cellular mechanisms of insulin resistance, Journal of Clinical Investigation, 106, 171, 10.1172/JCI10583 Garg, 2002, Hepatic steatosis, insulin resistance, and adipose tissue disorders, Journal of Clinical Endocrinology and Metabolism, 87, 3019, 10.1210/jc.87.7.3019